Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys to Cut 10 Percent of Staff to Save $6M Per Year; Will Trim UK Facility

NEW YORK, March 9 (GenomeWeb News) - Accelrys is cutting about 50 jobs, or 10 percent of its workforce, in an effort to save $6 million annually, according to an SEC filing yesterday.

 

The company said the cutbacks began on Tuesday and should be completed by the first quarter of its 2007 fiscal year.

 

Accelrys also plans to close a portion of its facilities in Cambridge, UK.

 

The company said it expects to incur between $3.5 million and $3.8 million in a one-time charge, including severance and facilities abandonment costs.

 

Accelrys said the actions "are intended to further realign the company's resources with its portfolio of products and services, eliminate redundancies ... and streamline operations."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.